Last reviewed · How we verify
A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma
This is a single-center, single-arm, open label and dose escalation clinical study of anti-CD147 CART cells by hepatic artery infusions in patients with advanced hepatocellular carcinoma.
Details
| Lead sponsor | Xijing Hospital |
|---|---|
| Phase | PHASE1 |
| Status | UNKNOWN |
| Enrolment | 34 |
| Start date | Mon May 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri May 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Advanced Hepatocellular Carcinoma
Interventions
- CD147-CART
Countries
China